1. Home
  2. PRE vs SKYE Comparison

PRE vs SKYE Comparison

Compare PRE & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRE
  • SKYE
  • Stock Information
  • Founded
  • PRE 2014
  • SKYE 2012
  • Country
  • PRE Hong Kong
  • SKYE United States
  • Employees
  • PRE N/A
  • SKYE N/A
  • Industry
  • PRE Biotechnology: Laboratory Analytical Instruments
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRE Industrials
  • SKYE Health Care
  • Exchange
  • PRE Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • PRE 69.7M
  • SKYE 80.7M
  • IPO Year
  • PRE N/A
  • SKYE N/A
  • Fundamental
  • Price
  • PRE $5.33
  • SKYE $2.98
  • Analyst Decision
  • PRE Buy
  • SKYE Buy
  • Analyst Count
  • PRE 1
  • SKYE 6
  • Target Price
  • PRE $9.00
  • SKYE $18.67
  • AVG Volume (30 Days)
  • PRE 18.1K
  • SKYE 223.9K
  • Earning Date
  • PRE 03-31-2025
  • SKYE 02-25-2025
  • Dividend Yield
  • PRE N/A
  • SKYE N/A
  • EPS Growth
  • PRE N/A
  • SKYE N/A
  • EPS
  • PRE N/A
  • SKYE N/A
  • Revenue
  • PRE $25,561,362.00
  • SKYE N/A
  • Revenue This Year
  • PRE $50.97
  • SKYE N/A
  • Revenue Next Year
  • PRE $217.53
  • SKYE N/A
  • P/E Ratio
  • PRE N/A
  • SKYE N/A
  • Revenue Growth
  • PRE N/A
  • SKYE N/A
  • 52 Week Low
  • PRE $2.85
  • SKYE $2.31
  • 52 Week High
  • PRE $7.84
  • SKYE $19.41
  • Technical
  • Relative Strength Index (RSI)
  • PRE 48.01
  • SKYE 48.34
  • Support Level
  • PRE $5.31
  • SKYE $2.97
  • Resistance Level
  • PRE $5.72
  • SKYE $3.31
  • Average True Range (ATR)
  • PRE 0.37
  • SKYE 0.37
  • MACD
  • PRE 0.00
  • SKYE 0.01
  • Stochastic Oscillator
  • PRE 60.34
  • SKYE 40.00

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: